Aurinia Pharmaceuticals
AUPH
#4781
Rank
A$2.97 B
Marketcap
A$22.21
Share price
-1.28%
Change (1 day)
-5.17%
Change (1 year)

Earnings for Aurinia Pharmaceuticals (AUPH)

Earnings in 2026 (TTM): A$0.24 Billion

According to Aurinia Pharmaceuticals 's latest financial reports the company's current earnings are A$0.32 Billion. In 2025 the company made an earning of A$0.17 Billion, an increase over its 2024 earnings that were of A$18.55 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Aurinia Pharmaceuticals from 1999 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$0.24 B38.94%
2025 A$0.17 B864.64%
2024 A$18.55 M-116.44%
2023 -A$0.12 Billion-31.8%
2022 -A$0.17 Billion-39.4%
2021 -A$0.28 Billion61.9%
2020 -A$0.17 Billion-9.73%
2019 -A$0.19 Billion92.65%
2018 -A$96.98 Million36.39%
2017 -A$71.11 Million106.29%
2016 -A$34.47 Million-15.4%
2015 -A$40.75 Million65.84%
2014 -A$24.57 Million129.82%
2013 -A$10.69 Million-26.6%
2012 -A$14.57 Million
2010 -A$8.25 Million-39.22%
2009 -A$13.57 Million-43.78%
2008 -A$24.14 Million-53.19%
2007 -A$51.56 Million42.97%
2006 -A$36.06 Million-23.03%
2005 -A$46.86 Million36.1%
2004 -A$34.43 Million172.57%
2003 -A$12.64 Million484.61%
2002 -A$2.17 Million
2000 -A$10.26 Million453.81%
1999 -A$1.86 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Regeneron Pharmaceuticals
REGN
A$8.59 B 3,225.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Pieris Pharmaceuticals
PIRS
-A$33.43 Million-112.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Aeterna Zentaris
AEZS
-A$8.29 Million-103.21%๐Ÿ‡บ๐Ÿ‡ธ USA